These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 32116500)

  • 1. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Front Neurosci; 2020; 14():43. PubMed ID: 32116500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Focus (Am Psychiatr Publ); 2024 Jul; 22(3):373-380. PubMed ID: 38988467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.
    Conn K; Milton LK; Huang K; Munguba H; Ruuska J; Lemus MB; Greaves E; Homman-Ludiye J; Oldfield BJ; Foldi CJ
    Mol Psychiatry; 2024 Oct; 29(10):3291-3304. PubMed ID: 38678087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.
    Koning E; Brietzke E
    Trends Psychiatry Psychother; 2024; 46():e20220597. PubMed ID: 37126863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the numbers: reimagining healing with psychedelics for eating disorders.
    Lafrance A; Spriggs MJ; Gukasyan N; Peck SK
    J Eat Disord; 2024 Sep; 12(1):148. PubMed ID: 39350242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Can Animal Models Inform the Understanding of Cognitive Inflexibility in Patients with Anorexia Nervosa?
    Huang K; Foldi CJ
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, automated, and experimenter-free touchscreen testing reveals reciprocal interactions between cognitive flexibility and activity-based anorexia in female rats.
    Huang K; Milton LK; Dempsey H; Power SJ; Conn KA; Andrews ZB; Foldi CJ
    Elife; 2023 Jun; 12():. PubMed ID: 37387293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Differences in Psychedelic Actions Based on Biological Sex.
    Shadani S; Conn K; Andrews ZB; Foldi CJ
    Endocrinology; 2024 Jul; 165(8):. PubMed ID: 38980913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelic Drugs in Biomedicine.
    Kyzar EJ; Nichols CD; Gainetdinov RR; Nichols DE; Kalueff AV
    Trends Pharmacol Sci; 2017 Nov; 38(11):992-1005. PubMed ID: 28947075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.
    Markopoulos A; Inserra A; De Gregorio D; Gobbi G
    Front Pharmacol; 2021; 12():749068. PubMed ID: 35177979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelic medicine: The biology underlying the persisting psychedelic effects.
    Kuypers KPC
    Med Hypotheses; 2019 Apr; 125():21-24. PubMed ID: 30902145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.
    Banushi B; Polito V
    Biology (Basel); 2023 Oct; 12(11):. PubMed ID: 37997979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.
    Romeo B; Hermand M; Pétillion A; Karila L; Benyamina A
    J Psychiatr Res; 2021 May; 137():273-282. PubMed ID: 33730602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic-Assisted Therapy for People with Eating Disorders.
    Gukasyan N; Schreyer CC; Griffiths RR; Guarda AS
    Curr Psychiatry Rep; 2022 Dec; 24(12):767-775. PubMed ID: 36374357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.
    Ross S
    Int Rev Psychiatry; 2018 Aug; 30(4):317-330. PubMed ID: 30102082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.
    Erritzoe D; Smith J; Fisher PM; Carhart-Harris R; Frokjaer VG; Knudsen GM
    J Psychopharmacol; 2019 Sep; 33(9):1068-1075. PubMed ID: 30816797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".
    Spriggs MJ; Douglass HM; Park RJ; Read T; Danby JL; de Magalhães FJC; Alderton KL; Williams TM; Blemings A; Lafrance A; Nicholls DE; Erritzoe D; Nutt DJ; Carhart-Harris RL
    Front Psychiatry; 2021; 12():735523. PubMed ID: 34744825
    [No Abstract]   [Full Text] [Related]  

  • 20. Classical psychedelics for the treatment of depression and anxiety: A systematic review.
    Muttoni S; Ardissino M; John C
    J Affect Disord; 2019 Nov; 258():11-24. PubMed ID: 31382100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.